Citius Oncology (CTOR) vs Alpha Teknova (TKNO)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Alpha Teknova (TKNO) has outperformed Citius Oncology (CTOR) over the past year, gaining 58.9% versus a loss of 54.7%. Alpha Teknova is the larger company by market cap ($453.1 million vs $88.3 million), about 5.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CTOR | TKNO |
|---|---|---|
| Share price | $0.835 | $8.44 |
| Market cap | $88.31M | $453.13M |
| 1-day change | -2.45% | -3.10% |
| YTD return | -14.90% | +122.11% |
| 1-year return | -54.73% | +58.95% |
| 5-year return | — | -63.46% |
| EPS (TTM) | $-0.48 | $-0.31 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.25 | $9.48 |
| 52-week low | $0.491 | $1.91 |
| Distance from 52-week high | -62.89% | -10.97% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +379.04% | +6.64% |
| Average volume | 99.72K | 232.69K |
| Shares outstanding | 105.76M | 53.69M |
| Employees | — | 158 |
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic | Drug Manufacturers - Specialty & Generic |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Alpha Teknova is about 5.1 times larger than Citius Oncology by market value ($453.13M vs $88.31M).
- TKNO has outperformed CTOR by 113.7 percentage points over the past year.
About Citius Oncology
CTOR stock →Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies.
Healthcare · Drug Manufacturers - Specialty & Generic
About Alpha Teknova
TKNO stock →Alpha Teknova, Inc. produces critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally.
Healthcare · Drug Manufacturers - Specialty & Generic · 158 employees
CTOR vs TKNO FAQ
Which is bigger, Citius Oncology or Alpha Teknova?
Alpha Teknova (TKNO) is larger, with a market capitalization of $453.13M compared with $88.31M for Citius Oncology (CTOR).
Which stock has performed better over the past year, CTOR or TKNO?
TKNO returned +58.95% over the past 12 months, compared with -54.73% for CTOR (price return, excluding dividends). Past performance does not predict future results.
Are Citius Oncology and Alpha Teknova in the same industry?
Yes. Both are classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.